Copenhagen-based digital health company specializing in chronic disease management, Dawn Health secured $13 million (€11.5 million) from existing investors Chr. Augustinus Fabrikker, the export and investment fund of Denmark (EIFO) and Trifork. WHAT IT DOES
Dawn…
What You Should Know:
– Pulse Charter Connect (PCC) has oversubscribed a $2 million seed round to modernize and streamline the way lifesaving organs are transported across the United States.
– The round was co-led by Ivy Ventures and…
Continue Reading
What You Should Know:
– Aktiia, a blood pressure intelligence platform, announces an oversubscribed $42 million Series B funding round, co-led by Earlybird Health and Wellington Partners, with new investors Kfund and NaturalX Health Ventures, and…
Continue Reading
Plenful, a workflow-automation platform for pharmacy and healthcare operations, has secured $50 million in Series B funding, bringing its total raise to $76 million. Dahner Corporation cofounder Mitchell Rales and Arena Holdings co-led the round,…
Continue Reading
What You Should Know:
– Epicore Biosystems, a leader in digital health solutions specializing in advanced sweat-sensing wearables, today announced an additional $6M in Series B funding.
– The funding brings the company’s total Series B…
Continue Reading
The University of Edinburgh has opened applications for its 2025 AI Accelerator programme.
The six-month programme, which will begin on 17 September 2025, enables AI-focused “scaleup” companies with a proven business model to connect with…
What You Should Know:
– Overture Life today announced a significant $20.6M strategic funding round, bringing its total capital raised to $57M from leading industry investors.
– Supported by Overwater Ventures, GV (formerly Google Ventures), and…
Continue Reading
New York-based Healthee, a healthcare benefits navigation platform, announced an oversubscribed $50 million Series B funding raise led by Key1 Capital. Existing investors Group11, Fin Capital and Glilot Capital Partners also participated in the round.
The…
Biolinq, a health technology company developing precision multi-analyte wearable biosensors for metabolic health, announced it secured $100 million in Series C funding. Alpha Wave Ventures led the round with participation from existing investors AXA IM…
Continue Reading
What You Should Know:
– Biolinq, a healthcare technology company focused on developing precision multi-analyte biosensors to improve metabolic health raises $100M in Series C financing round led by Alpha Wave Ventures, with participation from…
Continue Reading
